TDOC
Teladoc Health Inc
NYSE · Health Care
$5.01
+0.28 (+5.92%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.67B | 2.47B | 190.40M | 196.92M | 169.36M |
| Net Income | -1,041,804,430 | -867,126,594 | 19.70M | 22.43M | 19.47M |
| EPS | — | — | — | — | — |
| Profit Margin | -39.0% | -37.0% | 10.4% | 11.4% | 11.5% |
| Rev Growth | +8.1% | +8.1% | +24.1% | +7.3% | +5.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 226.02M | 226.02M | 315.71M | 331.89M | 372.61M |
| Total Equity | 218.55M | 218.55M | 631.81M | 654.10M | 617.48M |
| D/E Ratio | 1.03 | 1.03 | 0.50 | 0.51 | 0.60 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -679,847,403 | -597,294,953 | 37.67M | 39.52M | 34.03M |
| Free Cash Flow | — | — | 13.89M | 11.14M | 11.84M |